Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 4:28 pm Purchase | 2021-12-31 | 13G | Atara Biotherapeutics, Inc. ATRA | Point72 Asset Management, L.P. | 185,366 5.200% | 2,645 (+1.45%) | Filing History |
| 2022-02-09 5:17 pm Sale | 2022-01-31 | 13G | Atara Biotherapeutics, Inc. ATRA | BAUPOST GROUP LLC | 324,945 9.190% | -39,415 (-10.82%) | Filing History |
| 2022-02-09 3:24 pm Purchase | 2021-12-31 | 13G | Atara Biotherapeutics, Inc. ATRA | The Vanguard Group | 283,021 8.000% | 57,490 (+25.49%) | Filing History |
| 2022-02-09 09:09 am Purchase | 2022-02-08 | 13G | Atara Biotherapeutics, Inc. ATRA | FMR LLC | 224,530 6.348% | 126,220 (+128.39%) | Filing History |
| 2022-02-03 4:41 pm Purchase | 2021-12-31 | 13G | Atara Biotherapeutics, Inc. ATRA | BlackRock Inc. BLK | 312,662 8.800% | 54,485 (+21.10%) | Filing History |
| 2022-01-07 3:41 pm Purchase | 2021-12-31 | 13G | Atara Biotherapeutics, Inc. ATRA | JPMORGAN CHASE & CO JPM | 297,036 8.300% | 55,896 (+23.18%) | Filing History |
| 2021-12-21 5:13 pm Purchase | 2021-12-20 | 13G | Atara Biotherapeutics, Inc. ATRA | Point72 Asset Management, L.P. | 182,721 5.200% | 182,721 (New Position) | Filing History |
| 2021-02-16 4:23 pm Sale | 2020-12-31 | 13G | Atara Biotherapeutics, Inc. ATRA | BRIDGER MANAGEMENT LLC | 60,990 1.800% | -56,324 (-48.01%) | Filing History |
| 2021-02-16 4:09 pm Purchase | 2020-12-31 | 13G | Atara Biotherapeutics, Inc. ATRA | Redmile Group, LLC | 314,545 9.900% | 94,780 (+43.13%) | Filing History |
| 2021-02-16 1:41 pm Purchase | 2020-12-31 | 13G | Atara Biotherapeutics, Inc. ATRA | Maverick Capital, Ltd. | 292,982 8.900% | 94,644 (+47.72%) | Filing History |
| 2021-02-16 08:19 am Sale | 2020-12-31 | 13G | Atara Biotherapeutics, Inc. ATRA | Camber Capital Management LP | 0 0.000% | -118,000 (Position Closed) | Filing History |
| 2021-02-12 3:12 pm Purchase | 2020-02-12 | 13G | Atara Biotherapeutics, Inc. ATRA | BAUPOST GROUP LLC | 364,360 11.070% | 32,004 (+9.63%) | Filing History |
| 2021-02-10 10:30 am Purchase | 2020-12-31 | 13G | Atara Biotherapeutics, Inc. ATRA | The Vanguard Group | 225,531 6.850% | 78,263 (+53.14%) | Filing History |
| 2021-01-28 5:56 pm Purchase | 2020-12-31 | 13G | Atara Biotherapeutics, Inc. ATRA | BlackRock Inc. BLK | 258,177 7.800% | 74,960 (+40.91%) | Filing History |
| 2021-01-08 11:43 am Purchase | 2020-12-31 | 13G | Atara Biotherapeutics, Inc. ATRA | JPMORGAN CHASE & CO JPM | 241,140 7.300% | 241,140 (New Position) | Filing History |